{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:23:31Z","timestamp":1791401011716,"version":"4.3.3"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T00:00:00Z","timestamp":1708128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJID Regions"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ijregi.2024.02.003","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T01:05:26Z","timestamp":1708563926000},"page":"228-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Hepatitis delta virus infection in Turkey: A meta-analysis of prevalence"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7848-4816","authenticated-orcid":false,"given":"Mehlika","family":"Toy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beg\u00fcm","family":"G\u00fcler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayra","family":"Somay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5856-5384","authenticated-orcid":false,"given":"Genco","family":"Gen\u00e7dal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihan","family":"Yurdaydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijregi.2024.02.003_bib0001","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-2893.2010.01353.x","article-title":"Natural history and treatment of chronic delta hepatitis","volume":"17","author":"Yurdayd\u0131n","year":"2010","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0002","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/1471-2334-11-337","article-title":"Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review","volume":"11","author":"Toy","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0003","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1478-3231.2008.01673.x","article-title":"Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis","volume":"28","author":"De\u011fertekin","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0004","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmi.2015.06.028","article-title":"Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study","volume":"21","author":"Tozun","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0005","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1001\/jama.1989.03420090085036","article-title":"Type D (delta) hepatitis","volume":"261","author":"Hoofnagle","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0006","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0007","series-title":"Comparative effectiveness review methods: clinical heterogeneity","author":"West","year":"2010"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0008","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2893.2010.01329.x","article-title":"Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: still a serious problem to consider","volume":"18","author":"Bahcecioglu","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0009","first-page":"45","article-title":"Yuksek Hepatit Delta Antikoru sikligi","volume":"11","author":"Bal","year":"2021","journal-title":"J Duzce University Health Sciences Institute"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0010","first-page":"137","article-title":"Seroprevalence of delta hepatitis in chronic hepatitis B patients: single center study","volume":"33","author":"Serin","year":"2019","journal-title":"FUMed J Health. Sci"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0011","first-page":"69","article-title":"The prevalence and clinical significance of delta antibody in hepatitis B virus infection","volume":"17","author":"Yurtsever","year":"2011","journal-title":"Viral Hepatit Derg"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0012","doi-asserted-by":"crossref","first-page":"56","DOI":"10.7197\/1305-0028.1034","article-title":"The incidence of delta hepatitis seropositivity in HBsAg positive patients","volume":"34","author":"Altinbas","year":"2012","journal-title":"Cumhuriyet Med J"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0013","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4274\/Vhd.18.05","article-title":"Seroprevalance of hepatitis B virus, hepatitis C virus and hepatitis D virus in healthy blood donors","volume":"18","author":"Sirmatel","year":"2012","journal-title":"Viral Hepat J"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0014","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.transci.2014.03.005","article-title":"Evaluation of hepatitis delta virus (HDV) infection in blood donors in western Turkey","volume":"50","author":"Uzun","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0015","first-page":"95","article-title":"Seroprevalence of serum HBsAg positivity and hepatitis delta virus infection among blood donors in Southeastern Turkey","volume":"165","author":"Mese","year":"2014","journal-title":"Clin Ter"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0016","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/cld.887","article-title":"Regional epidemiology, burden, and management of hepatitis B virus in the Middle East","volume":"14","author":"Aky\u0131ld\u0131z","year":"2019","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0017","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1186\/s12879-020-05405-9","article-title":"Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety","volume":"20","author":"Omidkhoda","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0018","first-page":"367","article-title":"Hepatitis B and hepatitis C seroprevalence in the center of Sanliurfa Province from southeastern Anatolia region and related risk factors","volume":"27","author":"Tekin","year":"2010","journal-title":"Trakya Univ Tip Fak Derg"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0019","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/jvh.13834","article-title":"The changing epidemiology of delta hepatitis in Turkiye over three decades: a systematic review","volume":"30","author":"Uraz","year":"2023","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0020","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0021","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/apt.16527","article-title":"Editorial: natural history of hepatitis delta virus-induced liver disease \u2013 less severe today but still needs attention","volume":"54","author":"Gen\u00e7dal","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0022","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/hep.31214","article-title":"Long-term study of hepatitis delta virus infection at secondary care centers: the impact of viremia on liver-related outcomes","volume":"72","author":"Kamal","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0023","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/apt.15521","article-title":"Long-term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia","volume":"51","author":"Palom","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0024","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0016-5085(99)70563-9","article-title":"Changing pattern of chronic hepatitis D in Southern Europe","volume":"117","author":"Rosina","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0025","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1111\/liv.15638","article-title":"HERACLIS-HDV cohort for the factors of underdiagnosis and prevalence of hepatitis D virus infection in HBsAg-positive patients","volume":"43","author":"Papatheodoridis","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0026","article-title":"Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D","volume":"4","author":"Palom","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0027","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/infdis\/jiz634","article-title":"Hepatitis delta virus infection: A large burden after all?","volume":"221","author":"Yurdaydin","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0028","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijid.2023.02.006","article-title":"Trends in chronic hepatitis B virus infection in Italy over a 10-year period: clues from the nationwide PITER and Master cohorts toward elimination","volume":"129","author":"Brancaccio","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0029","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jhep.2020.06.038","article-title":"Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta","volume":"73","author":"Roulot","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0030","first-page":"203","article-title":"Hepatitis delta virus epidemiology in the industrialized world","volume":"22","author":"Toy","year":"2020","journal-title":"AIDS Rev"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0031","first-page":"339","article-title":"Hepatitis A, B, C and HIV seroprevalence among Syrian refugee children admitted to outpatient clinics","volume":"25","author":"K\u00f6se","year":"2017","journal-title":"Infez Med"},{"key":"10.1016\/j.ijregi.2024.02.003_bib0032","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2023.05.001","article-title":"Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL Clinical Practice Guidelines on hepatitis delta virus","volume":"79","year":"2023","journal-title":"J Hepatol"}],"container-title":["IJID Regions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707624000134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707624000134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T12:31:40Z","timestamp":1757421100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772707624000134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":32,"alternative-id":["S2772707624000134"],"URL":"https:\/\/doi.org\/10.1016\/j.ijregi.2024.02.003","relation":{},"ISSN":["2772-7076"],"issn-type":[{"value":"2772-7076","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis delta virus infection in Turkey: A meta-analysis of prevalence","name":"articletitle","label":"Article Title"},{"value":"IJID Regions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijregi.2024.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}